RGX-111

· REGENXBIO Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for RGX-111, covering 2024-07-03 to 2026-03-12. Get the full timeline:

Most recent: Clinical Trial Update: RGX-111 Gene Therapy in Patients With MPS I [Phase 1, Phase 2]